![]()
张映熠
- 教师拼音名称：Zhang Yingyi
- 出生日期：1985-01-13
- 性别：女
- 职称：副教授
- 所属院系：卫生应急学院
- 3d2f11f7ab7a6b83cf35d37278eb02ff43b07a04918f4fa517f63e4e0c1027f1c3afc9013d727abb7adc35dedd02886b0a3c53ec669ee4bf7a3d324974ca840519fbee519693cba5de11017064a2a7cfe85253d45554f7c20fcedf7409dbc00251ac6f7efa21e1a02f80a5a313a679e33a0f5fb1518b91e4d358fb0a3cbefd0c
- 374afedb095c06bc6afd888520d2cb6356e7f4fb4a93dd7c2817dc6f0a84f3901522be15f9d7584b48df4e85f04470fb61d23552ace12bd46592f22bcea97e344f5ceaf700168fc16c2dc7a7320e8728a4b2e033d44cc0cddf9debeb3199b92d79abec59997945340d926a30a1b7fb658c288505c31f5777f75eabc989798ad4
- a34453c3e4be9278c737921f6059640fdd2d37f430e17e7c5d06d7964ed92c57c77db15ad2170ff22a7002b2bab89e42e9827410257ecaa0e4a8bbb36ffe704168d536cf39ceca9d4ea3505f1ecbf72e43b53c57752e16d0d857b894100bcbbf560189e485d454be9d8de14d7ef1f1e53a940a5a5e3b1bc640a958cc1b3920e0
- 09d14a8a098d988bdeb60703e075140c3676cc18bb3dc01a475f9ea2e7d2088a25d5d1dd353e28c70aba29884b187e73f7d8cebab684359a61971e4eaf4dde6b5b438be358e227fcee6c8001ff881a84a1cf0682ab38be3c316334ad13b4f6c93bbaca981252b755f71693daed52d54c789fa12eeb4270c1c268b3c282e55548
-
· He K, Sun X, Chen C, Luc S, Hao Robichaud JL, Zhang Y, Huang Y, Ji B, Ku P-I, Subramanian R. Non-canonical CDK6 activity promotes cilia disassembly by suppressing axoneme polyglutamylation. J. Cell Biol. 2025, 222(3): e202405170. DOI: 10.1083/jcb.202405170.
-
· Li Y, Wang C, Gao H, Gu J, Zhang Y, Zhang Y, Xie M, Cheng X, Yang M, Zhang W. KDM4 inhibitor SD49-7 attenuates leukemia stem cell via KDM4A/MDM2/p21<sup>CIP1</sup> axis. Theranostics 2022, 12(10): 4565-4579. DOI: 10.7150/thno.71460.
-
· Hong H, Chen H, Zhang Y, Wu Z, Zhang Y, Zhang Y, Hu Z, Zhang JV, Ling K, Hu J. DYF-4 regulates patched-related/DAF-6-mediated sensory compartment formation in C. elegans. PLoS Genet. 2021, 17(6): e1009618. DOI: 10.1371/journal.pgen.1009618.
-
· Liu S, Li L, Zhang Y, Zhang Y, Zhao Y, You X, Lin Z, Zhang X, Ye L. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells. J. Biol. Chem. 2012, 287(20): 16828-16839. DOI: 10.1074/jbc.M112.343947.
-
· Liu Q, Bai X, Li H, Zhang Y, Zhao Y, Zhang X, Ye L. The oncoprotein HBXIP upregulates Lin28B via activating TFIID to promote proliferation of breast cancer cells. Int. J. Cancer 2013, 132(11): 2550-2561. DOI: 10.1002/ijc.28154.
-
· Fang R, Xu F, Shi H, Wu Y, Cao C, Li H, Ye K, Zhang Y, Liu Q, Zhang S. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity. Oncogene 2020, 39(6): 1234-1245. DOI: 10.1038/s41388-019-1146-2.
-
· Yue L, Li L, Liu F, Hu N, Zhang W, Bai X, Li Y, Zhang Y, Fu L, Zhang X. The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells. Carcinogenesis 2013, 34(4): 927-935. DOI: 10.1093/carcin/bgs399.
-
· Cui W, Zhao Y, Shan C, Kong G, Hu N, Zhang Y, Zhang S, Zhang W, Zhang Y, Zhang X. HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack. FEBS Lett. 2012, 586(6): 782-787. DOI: 10.1016/j.febslet.2012.01.039.
